expert roundtable discussion
Biomarkers Roundtable:
Practical Insights from Ligand Binding and Molecular Assays
THURSDAY, APRIL 2nd | 1:30PM EST
Biomarkers shape decisions from discovery through late-stage clinical trials.
But the wrong assay plan can waste time, budget and samples. In this KCAS Bio roundtable, we share practical ways to align context of use, assay design and platform choice so your biomarker data supports real decisions.
Speakers
Dominic Warrino, PhD
Senior Director of Scientific Services
Carrie Vyhlidal, PhD
Associate Director,
BioPharma Sciences-Molecular
Lindsay Rutherford, PhD
Senior Scientific Advisor
Register now
Don't miss this chance to learn and get your questions answered
What you'll learn
How to define context of use so your biomarker strategy holds up as studies scale
When a ligand binding assay (LBA) makes sense vs a molecular approach
What “fit for purpose” can look like across early research, preclinical and clinical stages